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Abstract Disruption of the actin cytoskeleton in AR4-2J
pancreatic acinar cells led to an increase in cytosolic protein
tyrosine phosphatase activity, abolished bombesin-induced tyr-
osine phosphorylation and reduced bombesin-induced amylase
secretion by about 45%. Furthermore, both tyrosine phospho-
rylation and amylase secretion induced by phorbol ester-induced
activation of protein kinase C were abolished. An increase in the
cytosolic free Ca2+ concentration by the Ca2+ ionophore A23187
had no effect on tyrosine phosphorylation but induced amylase
release. Only when added together with phorbol ester, the same
level of amylase secretion as with bombesin was reached. This
amylase secretion was inhibited by about 40% by actin
cytoskeleton disruption similar to that induced by bombesin.
We conclude that actin cytoskeleton-controlled protein tyrosine
phosphatase activity downstream of protein kinase C activity
regulates tyrosine phosphorylation which in part is involved in
bombesin-stimulated amylase secretion.
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1. Introduction
In di¡erent cell types, cellular responses to hormones and/
or growth factors are mediated by the activation of tyrosine
kinases [1]. Phosphorylation of tyrosine residues in speci¢c
proteins is due to the activity not only of tyrosine kinases,
but also of protein tyrosine phosphatases (PTPases). Speci¢c
PTPase inhibitors, such as pervanadate [2], are useful tools in
the study of hormone- and growth factor-induced protein ty-
rosine phosphorylation. Recently, we have shown that incu-
bation of di¡erentiated rat pancreatic AR4-2J cells with per-
vanadate, similar to bombesin, leads to amylase secretion and
to tyrosine phosphorylation of p125FAK and paxillin [3]. Our
data suggested that protein tyrosine phosphorylation down-
stream of protein kinase C (PKC) activation is involved in
stimulation of enzyme secretion from these cells [3].
Previously, it has been reported that in Swiss 3T3 cells, an
increased tyrosine phosphorylation of p125FAK and paxillin is
accompanied by a profound reorganization of the actin cytos-
keleton and by the assembly of focal adhesion plaques, dis-
tinct sites in the plasma membrane where both p125FAK and
paxillin are localized [4,5]. Studies using cytochalasin D,
which selectively disrupts the actin cytoskeleton network,
demonstrated that bombesin-induced tyrosine phosphoryla-
tion of p125FAK and paxillin depends on the integrity of the
actin cytoskeleton [4,6]. Work during the past 5 years has
shown that small GTP-binding proteins of the Ras superfam-
ily, the Rho proteins Rho, Rac and Cdc42, are involved in the
control of the actin cytoskeleton organization (reviewed in
[7]). Small GTP-binding proteins and actin are selectively
modi¢ed and thereby inactivated by clostridial cytotoxins
[8^10]. Clostridium botulinum exoenzyme C3 is a transferase
which inactivates Rho (RhoA, RhoB, RhoC) by ADP-ribosy-
lation at Asn41 [11]. Both toxin A and toxin B from Clostri-
dium di⁄cile monoglucosylate Rho, Rac and Cdc42 by trans-
fer of glucose to threonine in the e¡ector domain (Thr37 of
Rho) [9,10]. In contrast to these toxins, the C2 toxin of C.
botulinum directly ADP-ribosylates actin at Arg177 [8]. Incu-
bation of cells with each of these toxins leads to the depoly-
merization of actin ¢laments and destruction of the actin cy-
toskeleton [8^10].
It was the purpose of this study to investigate if the actin
cytoskeleton organization plays a role in the signal cascade of
stimulus-secretion coupling in rat pancreatic AR4-2J acinar
cells. Our data show that destruction of the actin cytoskeleton
leads to an increase in the cytosolic PTPase activity. Conse-
quently, bombesin-induced tyrosine phosphorylation of both
p125FAK and paxillin is decreased. Destruction of the actin
cytoskeleton also leads to a reduction of about 45% in bomb-
esin-stimulated amylase release and abolishes amylase release
stimulated by the PKC activator phorbol 12-myristate 13-ace-
tate (PMA) after 30 min of incubation, whereas the Ca2-
induced amylase secretion is not a¡ected. We assume that
regulation of the organization of the actin cytoskeleton, which
in turn controls the PTPase activity, plays an important role
in protein secretion from pancreatic AR4-2J cells.
2. Materials and methods
2.1. Materials
C. di⁄cile toxin B was prepared as described [12]. Genistein, cyto-
chalasin D, calcium ionophore A23187 and PMA were obtained from
Calbiochem (Bad Soden, Germany) and were prepared in dimethyl
sulfoxide as stock solutions. Anti-phosphotyrosine antibody (clone
PY20) was purchased from Santa Cruz (Heidelberg, Germany) and
anti-p125FAK antibody (clone 2A7) from Biomol (Hamburg, Ger-
many). Anti-paxillin antibody (clone 349) and protein G PLUS/pro-
tein A-agarose were obtained from Dianova (Hamburg). Peroxide of
vanadate (pervanadate) was prepared by mixing vanadate (Sigma,
Deisenhofen, Germany) with H2O2 (Merck, Darmstadt, Germany)
for 15 min at room temperature, followed by the addition of catalase
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(Sigma) to remove residual H2O2 as described by Fantus et al. [13].
Fetal calf serum was obtained from PAA Laboratories (Co«lbe, Ger-
many) and penicillin/streptomycin from Gibco (Eggenstein, Ger-
many). Leupeptin was purchased from Serva (Heidelberg) and trypsin
inhibitor (hen egg white) from Boehringer (Mannheim). Dulbecco’s
modi¢ed Eagle’s medium (DMEM) was from Sigma. All the other
reagents were of analytical grade and commercially available.
2.2. Cell culture and treatment with toxins
AR4-2J cells were obtained from the American Type Culture Col-
lection (ATCC number CRL 1492) (Rockville, MD, USA). The cells
were seeded at 750 000 cells per 35 mm Petri dish and were routinely
grown for 72 h in DMEM supplemented with 10% (v/v) fetal calf
serum, 100 U/ml penicillin and 100 Wg/ml streptomycin at 37‡C in a
humidi¢ed atmosphere of 95% air and 5% CO2. Di¡erentiation of the
cells was induced by addition of 100 nM dexamethasone. After 48 h,
the medium was changed and the cells were incubated with toxins (C.
di⁄cile toxin B or cytochalasin D) or without toxins for the indicated
times. After toxin treatment, cells were washed with the appropriate
bu¡er and used for the assays.
2.3. Amylase release
For measurement of the amylase release, toxin-treated and un-
treated AR4-2J cells were washed three times with KRH bu¡er (which
contained in mM: 130 NaCl, 5 KCl, 2 MgCl2, 1.2 KH2PO4, 1 CaCl2,
20 HEPES, 10 glucose, 0.1 mg/ml trypsin inhibitor, pH 7.4) and pre-
incubated for 10 min at 37‡C. The cells were stimulated by addition of
agonists and at indicated times, aliquots of the supernatants were
removed for the determination of amylase released by the cells. For
measurement of the total amount of amylase, the cells were scraped
o¡ and lysed in a bu¡er containing (in mM) 5 HEPES, pH 7.0,
280 mannitol, 10 KCl, 1 MgCl2, 1 benzamidine, 0.001 leupeptin,
0.2 PMSF, 20 Wg/ml trypsin inhibitor and 0.1% (v/v) Triton X-100.
The amylase activity was determined using the Phadebas Amylase
Test (Pharmacia, Freiburg, Germany) and was expressed as percent-
age of the total cellular content of amylase present at the beginning of
the incubation.
2.4. Tyrosine phosphorylation and immunoprecipitation
For the determination of tyrosine phosphorylation, toxin-treated
and untreated AR4-2J cells were washed three times with KRH bu¡er
and pre-incubated with or without tyrosine kinase inhibitor for 10 min
at 37‡C. Bombesin or pervanadate were added for the indicated times
followed by washing the cells with ice-cold PBS containing 0.5 mM
sodium orthovanadate. Cells were then scraped o¡ and lysed in a lysis
bu¡er containing (in mM) 10 Tris-HCl, pH 7.5, 50 NaCl, 5 EDTA,
0.5 sodium orthovanadate, 30 sodium pyrophosphate, 50 NaF,
1 PMSF, 0.5 Wg/ml leupeptin and 0.5% (v/v) Triton X-100. After
sonication of the cell lysates, three times concentrated electrophoresis
sample bu¡er [14] was added and the samples were boiled for 5 min to
denature proteins. For immunoprecipitation, 500 Wl lysate containing
500 Wg of total protein was incubated with 1.5^3 Wg primary antibody
for 60 min on ice. After this time, 30 Wl of a 30% suspension of
protein G-PLUS/protein A-agarose in PBS was added and the sam-
ples were incubated for an additional 60 min with agitation at 4‡C.
The agarose beads were centrifuged and washed three times with
10 mM Tris-HCl, pH 8.0, 150 mM NaCl and 0.1% (v/v) Triton
X-100. Then, the beads were resuspended in electrophoresis sample
bu¡er [14] and boiled for 5 min to release precipitated proteins from
the beads.
2.5. In vitro PTPase assay
AR4-2J cells were incubated with toxin B (10 ng/ml) or 5 WM
cytochalasin D for 20 h. After washing with ice-cold PBS, cells were
harvested in 10 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1 mM PMSF
and 0.5 Wg/ml leupeptin and sonicated twice for 5 s on ice. Then, cell
homogenates were centrifuged for 5 min at 4‡C and 350Ug. The
supernatant was further centrifuged for 15 min at 4‡C and
30 000Ug and the resulting supernatant was used as ‘cytosol’ for
determination of the PTPase activity. As substrate, paxillin was tyro-
sine-phosphorylated by incubation of cells with 100 WM pervanadate
for 15 min and immunoprecipitated with 1.5 Wg anti-paxillin antibody
from 400 Wg total cell protein as described above. This immunopre-
cipitated paxillin was incubated for up to 45 min with ‘cytosol’ (0^1.5
mg/ml protein) obtained from untreated or toxin-treated cells in the
absence or presence of pervanadate as indicated. The reaction was
terminated by addition of half the volume of three times concentrated
electrophoresis sample bu¡er and by boiling for 5 min to denature the
proteins.
2.6. Electrophoresis and immunoblotting
Proteins were electrophoretically separated in SDS-polyacrylamide
gels [14]. Electrotransfer to nitrocellulose membranes for 60 min at
0.8 mA/cm2 was done in a bu¡er which contained 48 mM Tris, 39 mM
glycine, pH 8.6, 0.0375% (w/v) SDS and 20% (v/v) methanol. Mem-
branes were blocked using 1% (w/v) bovine serum albumin in Tris-
bu¡ered saline (10 mM Tris-HCl, pH 8.0 and 150 mM NaCl) for
60 min and incubated for 60 min with primary antibodies diluted in
Tris-bu¡ered saline plus 0.2% (v/v) Tween 20. Bound antibodies were
visualized with secondary antibodies conjugated to horseradish per-
oxidase using an enhanced chemiluminescence detection kit (Amer-
sham, Braunschweig, Germany) and Re£ection autoradiography ¢lm
(NEN Life Science Products). The density of bands on the ¢lm was
measured using a scanning densitometer (Fro«bel Labortechnik, Lin-
dau, Germany).
2.7. Protein determination
Protein was assayed as described by Bradford [15] using bovine
serum albumin as standard.
3. Results and discussion
3.1. The e¡ect of toxin B on bombesin- and
pervanadate-induced protein tyrosine phosphorylation
Our recent studies support the view that protein tyrosine
phosphorylation is involved in secretagogue-induced amylase
secretion from AR4-2J cells [3]. Rozengurt and coworkers
have shown that the integrity of the actin cytoskeleton is
essential for hormone-induced protein tyrosine phosphoryla-
tion in Swiss 3T3 cells [4,6]. We therefore examined if the
actin cytoskeleton organization a¡ects the protein secretion
in AR4-2J cells by the use of C. di⁄cile toxin B and cytocha-
lasin D. Toxin B has been identi¢ed as monoglucosyltransfer-
ase [9] and has been shown to inactivate Rho proteins [16].
After treatment of AR4-2J cells with toxin B (10 ng/ml) for 20
h, all target proteins known for toxin B-induced inactivation
were found to be nearly completely glucosylated in intact
AR4-2J cells (results not shown). The inactivation of Rho
proteins by toxin B resulted in a rounding up of the cells
indicating a change in the organization of their actin cytoske-
leton (results not shown). Similarly, treatment of AR4-2J cells
with 5 WM cytochalasin D, which directly inhibits actin
polymerization, changed the organization of the actin cyto-
skeleton of AR4-2J cells (results not shown).
Using a monoclonal antibody to phosphotyrosine, we ex-
amined by immunoblot analysis if the actin ¢lament destroy-
ing toxins a¡ects the hormonal-induced protein tyrosine phos-
phorylation in AR4-2J cells. As shown in Fig. 1A, left panel,
AR4-2J cells stimulated with bombesin for 15 min showed a
signi¢cant increase in tyrosine phosphorylation of proteins
with an apparent molecular mass of 120^140 kDa and of
about 70 kDa. In the presence of toxin B, bombesin-induced
tyrosine phosphorylation of these proteins was completely in-
hibited, similar as with the tyrosine kinase inhibitor genistein.
In the presence of cytochalasin D, also a complete inhibition
of bombesin-induced tyrosine phosphorylation was observed.
In addition, there was a strong increase in tyrosine phospho-
rylation of proteins in the range of 145 kDa and a small
increase in tyrosine phosphorylation of proteins of 85 and
56 kDa. The identity of these protein bands cannot be
assigned at present.
Reduction in the bombesin-induced protein tyrosine phos-
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phorylation by toxin B or cytochalasin D could be either due
to the inhibition of tyrosine kinase activity, similar as with
genistein, and/or due to an increase in PTPase activity which
overrides the bombesin-stimulated tyrosine kinase activity. To
check both possibilities, AR4-2J cells pre-treated without or
with either genistein, toxin B or cytochalasin D were incu-
bated with 100 WM pervanadate for 15 min to inhibit
PTPases. As reported previously [3] and shown in Fig. 1B,
right panel, pervanadate induced tyrosine phosphorylation
of multiple proteins including 120^140 and 70 kDa proteins.
Whereas genistein reduced the total protein tyrosine phos-
phorylation by about 95%, treatment of the cells with toxin
B or cytochalasin D had no e¡ect on the pervanadate-induced
protein tyrosine phosphorylation.
The focal adhesion-associated proteins p125FAK and paxil-
lin are the most prominent tyrosine-phosphorylated proteins
in bombesin-treated AR4-2J cells [3]. As shown in Fig. 1B, left
panel, bombesin-induced tyrosine phosphorylation of
p125FAK was about 5-fold higher than the control and was
completely inhibited by treatment of cells with each of the
toxins and inhibitors tested. Bombesin-induced tyrosine phos-
phorylation of paxillin was about 3-fold higher than the con-
trol. It was reduced to basal levels by treatment of the cells
with genistein or cytochalasin D and completely inhibited by
toxin B treatment (Fig. 1C, left panel). The tyrosine phos-
phorylation of p125FAK induced by pervanadate was about
30-fold of the control and was reduced by about 95% by
genistein and surprisingly also inhibited by about 40 and
50% by toxin B or cytochalasin D, respectively (Fig. 1B, right
panel). The pervanadate-induced tyrosine phosphorylation of
paxillin was about 12-fold of the control and was reduced by
about 90% by genistein, but was signi¢cantly reduced neither
by toxin B nor by cytochalasin D (Fig. 1C, right panel).
Since these toxins lead to depolymerization of the actin
cytoskeleton, we conclude that an intact actin cytoskeleton
inhibits the PTPase activity. In order to test if the destruction
of the actin cytoskeleton increases the PTPase activity, cytosol
from control and toxin-treated cells was incubated with highly
tyrosine-phosphorylated paxillin prepared by immunoprecipi-
tation after incubation of the cells with pervanadate. The
phosphotyrosine content of paxillin was analyzed after SDS-
PAGE and immunoblotting using the monoclonal anti-phos-
photyrosine antibody. As shown in Fig. 2A, in the presence of
cytosol prepared from toxin B- or cytochalasin D-treated
cells, the tyrosine phosphorylation of paxillin was time-de-
pendently reduced, whereas cytosol from untreated cells
caused only a small reduction in tyrosine phosphorylation
of paxillin. Tyrosine phosphorylation of paxillin was not re-
duced by incubation with cytosol from untreated or toxin-
treated cells when cytosol was pre-incubated with 100 WM
of the PTPase inhibitor pervanadate for 10 min, indicating
that the reduction in tyrosine phosphorylation of paxillin is
Fig. 1. The e¡ect of genistein, C. di⁄cile toxin B and cytochalasin
D on bombesin- or pervanadate-induced tyrosine phosphorylation
of p125FAK and paxillin. Di¡erentiated AR4-2J cells were incubated
in DMEM in the absence or presence of toxin B (10 ng/ml) for 21 h
or with 5 WM cytochalasin D for 2 h. Cells were then washed with
KRH bu¡er and pre-incubated in the absence or presence of
100 WM genistein for 10 min at 37‡C. Then, cells were treated with
10 nM bombesin or with 100 WM pervanadate for 15 min at 37‡C.
After lysis of the cells, immunoprecipitations of p125FAK and paxil-
lin were performed. Total cell lysates (A) and immunoprecipitates of
p125FAK (B) and paxillin (C) were subjected to SDS-PAGE and im-
munoblotting was performed using anti-phosphotyrosine antibodies
as described in Section 2. The experiment shown is representative
for three (immunoprecipitation) and four (total cell lysates) separate
experiments, respectively.
Fig. 2. The e¡ect of C. di⁄cile toxin B and cytochalasin D on
PTPase activity in the cytosol of AR4-2J cells. Tyrosine-phosphory-
lated paxillin which was prepared as described in Section 2 was in-
cubated with cytosol (1.33 mg/ml protein) from untreated (control)
or toxin-treated cells (10 ng/ml toxin B, 5 WM cytochalasin D for
20 h) for the indicated times (A) in the absence or presence of
100 WM pervanadate (pv) for 30 min at 25‡C (B). After termination
of the reaction, samples were subjected to SDS-PAGE and the level
of tyrosine phosphorylation of paxillin was determined following
immunoblotting using anti-phosphotyrosine antibodies as described
in Section 2. The immunoblot shown in the upper panel is a repre-
sentative of three separate experiments. To quantify the level of ty-
rosine phosphorylation, the density of bands on the ¢lm was deter-
mined using a scanning densitometer. The values (mean þ S.D.)
from three independent experiments are shown in the lower panel
and are expressed as percentage of maximal tyrosine phosphoryla-
tion of paxillin.
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due to PTPase activity present in the cytosol (Fig. 2B).
Probing the same samples with an anti-paxillin antibody de-
tected equal amounts of paxillin, indicating that immunopre-
cipitated paxillin was not degraded by incubation with cytosol
from toxin B- or cytochalasin D-treated cells (results not
shown). These results indicate that an intact actin cytoskele-
ton suppresses or negatively regulates PTPase activity and
that disruption of the actin cytoskeleton ceases PTPase inhib-
ition. Our data are in agreement with a report which suggests
that assembly of the actin cytoskeleton plays a role in inhib-
ition of PTPases involved in p125FAK tyrosine phosphoryla-
tion in human endothelial and Chinese hamster ovary cells
[17].
In addition to a reduction in the pervanadate-induced
p125FAK tyrosine phosphorylation by cytosol from toxin B-
or cytochalasin D-treated cells (Fig. 1B, left panel), a small
reduction in tyrosine phosphorylation could be observed even
at inhibited cytosolic tyrosine phosphatase in the presence of
pervanadate (Fig. 1B, right). This indicates that at least one
speci¢c tyrosine kinase is partially inhibited by an actin cyto-
skeleton disruption whereas the overall tyrosine kinase activ-
ity is not a¡ected (Fig. 1A, right panel). In order to further
test if destruction of the actin cytoskeleton inhibits the tyro-
sine kinase activity, we incubated AR4-2J cells with toxin B
for 20 h. To stimulate tyrosine kinase activities, untreated and
toxin B-pre-treated cells received bombesin for 15 and 30 min.
Cytosol was prepared from these cells and was added to phos-
phorylated and immunoprecipitated p125FAK or paxillin in
the presence of 0.5 mM ATP, 5 mM MgCl2 and with 100
WM pervanadate to inhibit PTPases. The phosphotyrosine
content of p125FAK and paxillin was analyzed after SDS-
PAGE and immunoblotting using the monoclonal anti-phos-
photyrosine antibody. Tyrosine phosphorylation of p125FAK
and paxillin was increased about 2-fold in the presence of
cytosol from cells which were stimulated with bombesin for
15 min as compared to cytosol from unstimulated cells. How-
ever, cytosol prepared from toxin B-pre-treated and bombe-
sin-stimulated cells increased tyrosine phosphorylation of
p125FAK and paxillin only by about 1.3-fold (results not
shown). This indicates that actin cytoskeleton disruption in
addition to tyrosine phosphatase activation also inhibits to
some extent the tyrosine kinase activity.
3.2. The e¡ect of toxin B on amylase secretion
In Fig. 3, the e¡ect of toxin B on amylase secretion is
illustrated. After 30 min of incubation, amylase secretion
from di¡erentiated AR4-2J cells was stimulated by a maxi-
mally e¡ective concentration of 10 nM bombesin from
7.0 þ 0.5% of total amylase in control cells to 18.9 þ 1.9%
(Fig. 3A). Pre-treatment of cells with toxin B (10 ng/ml) for
21 h showed no signi¢cant di¡erence in the bombesin-stimu-
lated secretion as compared to untreated cells within the ini-
tial 10 min. However, after 30 min of stimulation, the amylase
secretion was reduced from 18.9 þ 1.9% to 13.4 þ 3.0% of total
amylase (P6 0.01) in toxin B-treated cells. As shown in Fig.
3B, bombesin-stimulated secretion was not further inhibited at
higher concentrations of up to 200 ng/ml toxin B, indicating
that the small inhibition of bombesin-stimulated amylase se-
cretion could not be due to insu⁄cient application of toxins.
Unstimulated amylase secretion was not a¡ected by any of the
tested toxin B concentrations. The partial inhibition of the
protein secretion by toxin B is also not due to incomplete
inactivation of Rho proteins, since all target proteins known
for toxin B-induced inactivation were found to be nearly com-
pletely glucosylated in intact AR4-2J cells by a toxin B con-
centration of 10 ng/ml (results not shown).
Two phases of exocytosis are proposed to occur in pancre-
atic acinar cells: an initial phase, which is completed within 5^
10 min of agonist stimulation, and a second phase, which is
sustained for the duration of hormonal stimulation [18].
Whereas the initial rapid phase is mediated by production
of inositol 1,4,5-trisphosphate followed by Ca2 release from
intracellular stores and Ca2 in£ux into the cell, the sustained
phase is associated with production of diacylglycerol and ac-
tivation of PKC [19,20]. Arti¢cial activation of these path-
ways by elevation of the cytosolic Ca2 concentration in the
presence of stimulators of PKC, such as the phorbol ester
PMA, could mimic the e¡ect of secretagogues on the enzyme
secretion [20^22]. In order to test if the partial inhibition of
amylase secretion by toxin B can be ascribed to inhibition of
either phase, we examined the amylase release from toxin B
pre-treated AR4-2J cells stimulated by an increase in the cy-
tosolic free Ca2 concentration and PKC activation. As
Fig. 3. The e¡ect of C. di⁄cile toxin B on unstimulated and bombe-
sin-stimulated amylase release from AR4-2J cells. A: Di¡erentiated
AR4-2J cells were incubated in DMEM in the absence or presence
of toxin B (10 ng/ml) for 21 h. Then, cells were washed and incu-
bated with KRH bu¡er for up to 30 min as control without (c) or
with 10 nM bombesin (bn). At indicated times, aliquots were re-
moved from the medium and amylase secreted into the medium was
quanti¢ed. The amylase release is expressed as percentage of the to-
tal amylase content of the cells present at the beginning of the incu-
bation (mean þ S.D., n = 5). B: Di¡erentiated AR4-2J cells were in-
cubated in DMEM with indicated toxin concentrations for 21 h.
Then, cells were washed and incubated in KRH bu¡er for 30 min
at 37‡C without (circles) and with 10 nM bombesin (triangles).
Amylase secreted into the medium after 30 min of incubation was
quanti¢ed and is expressed as percentage of the maximal amylase
secretion induced by 10 nM bombesin ( = 100%) (mean þ S.D.,
n = 4). The signi¢cance of the di¡erences between values from un-
treated and toxin-treated cells was calculated using the t-test for
paired values: *P6 0.01.
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shown in Fig. 4A, an increase in the cytosolic free Ca2 con-
centration by the calcium ionophore A23187 increased the
amylase secretion within the ¢rst 10 min and thereafter
showed no higher secretion rate than the unstimulated control
cells. However, A23187 enhanced the PMA-stimulated amy-
lase release to levels comparable to those induced by bomb-
esin, whereas PMA alone increased amylase release only after
10 min of incubation. Pre-treatment of cells with toxin B
nearly completely abolished PMA-stimulated amylase release,
whereas amylase secretion induced by A23187 alone was not
inhibited. Similar to inhibition of bombesin, PMA plus
A23187-induced amylase release was also inhibited by 40%.
These data demonstrate that toxin B a¡ects the PKC-stimu-
lated but not the Ca2-stimulated pathway leading to amylase
secretion. Our recent data suggest that in the cascade of
events that leads to bombesin-induced protein secretion in
AR4-2J cells, protein tyrosine phosphorylation occurs down-
stream of PKC [3]. Tyrosine phosphorylation of paxillin in-
duced by PMA started after about 10 min of incubation and
reached after 30 min the level of maximal tyrosine phospho-
rylation that was induced by bombesin (results not shown).
The onset of paxillin tyrosine phosphorylation correlated
with PMA-induced amylase release which began after 10
min (Fig. 4A) and was in the same range as the amylase
release induced by bombesin after 60 min of incubation [3].
Protein tyrosine phosphorylation induced by bombesin (Fig.
1) or PMA (results not shown) is completely inhibited by
treatment of the cells with toxin B due to an increased tyro-
sine phosphatase activity. Inhibition of PTPase activity by
pervanadate resulted in a tyrosine phosphorylation which
was inhibited by toxin B to some extent only due to partial
inhibition of a tyrosine kinase (Fig. 1B, right). Inhibition of
tyrosine dephosphorylation in the presence of pervanadate led
to amylase secretion, which was nearly identical to that in-
duced by PMA and was additive to that induced by A23187
(Fig. 4B) [3]. These data suggest that both protein tyrosine
phosphorylation and the increase in the cytosolic free Ca2
concentration act synergistically in stimulated amylase secre-
tion. Treatment of cells with toxin B did not inhibit amylase
secretion induced by pervanadate alone or in combination
with A23187 (Fig. 4B). These observations suggest that partial
inhibition (35^45%) of bombesin-stimulated amylase secretion
by toxin B may be due to complete inhibition of protein
tyrosine phosphorylation. The pathway stimulated by Ca2
is not a¡ected by actin cytoskeleton disruption. Therefore,
about 55^65% of the bombesin-stimulated amylase release re-
mains una¡ected in the presence of toxin B. This result is
opposite to that of Jena et al. [23] who showed that the in-
troduction of a recombinant form of rat brain PTPase
(rrbPTP-1) into permeabilized rat pancreatic acinar cells in-
creased the Ca2-mediated secretion. Since the actin cytoske-
leton-controlled PTPase has not yet been identi¢ed, the appa-
rent discrepancy with the studies of Jena et al. [23] awaits
further clari¢cation.
Taken together, the results of this study demonstrate a
striking correlation between actin cytoskeleton formation,
protein tyrosine phosphorylation and secretion. We assume
that activation of PTPase(s) by disassembly of the actin cy-
toskeleton leads to protein tyrosine dephosphorylation and
consequent inhibition of protein secretion. Protein tyrosine
phosphorylation occurs in a Ca2-independent manner down-
stream of PKC activation, whereas Ca2 plays a role in the
¢nal step of exocytosis [3]. At present, neither the tyrosine
kinase nor the PTPase, which could be involved in protein
secretion, has been identi¢ed. If p125FAK and/or paxillin,
which are mainly tyrosine-phosphorylated in the presence of
bombesin, are involved in stimulus-secretion coupling in AR4-
2J cells has to be investigated in future studies.
Fig. 4. The e¡ect of C. di⁄cile toxin B on PMA-, pervanadate- and calcium ionophore A23187-stimulated amylase secretion. Di¡erentiated
AR4-2J cells were incubated in DMEM in the absence or presence of toxin B (10 ng/ml) for 20 h. Then, cells were washed with KRH bu¡er
and were left unstimulated (addition of a corresponding volume of vehicle, control (c)) or were stimulated by the addition of 10 nM bombesin
(bn), 400 nM PMA, 100 WM pervanadate or 5 WM A23187 alone or in combinations as indicated. Amylase secretion over 30 min was meas-
ured as described in the legend to Fig. 1. For clarity, the e¡ect of PMA on the amylase release is shown in A and the e¡ect of pervanadate on
amylase release is shown in B. Data shown in A and B are from the same series of experiments (n = 4).
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